Fatal septic shock due to Lancefield group G streptococci. 1996

P M Honoré, and A Lozana, and D Defalque, and A Estratiou
Intensive Care Unit, Guy's Hospital, London, U. K.

We describe two cases of fatal septic shock caused by Lancefield group G streptococci. Both were community-acquired and occurred in previously healthy adults. Both patients died in severe multiple organ failure despite prompt antibiotic therapy. Serological typing of bacterial cultures identified the T-protein antigen as serotype 300, but this was thought to be of little relevance to the pathogenesis; T-protein antigens are useful as epidemiological markers. M-typing and PCR (polymerase chain reaction) detection of the streptococcal pyrogenic exotoxin genes were found to be negative suggesting that this highly pathogenic organism may represent a new M-type.

UI MeSH Term Description Entries
D008297 Male Males
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D013290 Streptococcal Infections Infections with bacteria of the genus STREPTOCOCCUS. Group A Strep Infection,Group A Streptococcal Infection,Group A Streptococcal Infections,Group B Strep Infection,Group B Streptococcal Infection,Group B Streptococcal Infections,Infections, Streptococcal,Infection, Streptococcal,Streptococcal Infection
D013297 Streptococcus pyogenes A species of gram-positive, coccoid bacteria isolated from skin lesions, blood, inflammatory exudates, and the upper respiratory tract of humans. It is a group A hemolytic Streptococcus that can cause SCARLET FEVER and RHEUMATIC FEVER. Flesh-Eating Bacteria,Streptococcus Group A,Bacteria, Flesh-Eating
D017809 Fatal Outcome Death resulting from the presence of a disease in an individual, as shown by a single case report or a limited number of patients. This should be differentiated from DEATH, the physiological cessation of life and from MORTALITY, an epidemiological or statistical concept. Fatal Outcomes,Outcome, Fatal,Outcomes, Fatal

Related Publications

P M Honoré, and A Lozana, and D Defalque, and A Estratiou
March 1985, Medicine,
P M Honoré, and A Lozana, and D Defalque, and A Estratiou
August 1969, Lancet (London, England),
P M Honoré, and A Lozana, and D Defalque, and A Estratiou
July 1989, Medicine,
P M Honoré, and A Lozana, and D Defalque, and A Estratiou
January 1980, Schweizerische medizinische Wochenschrift,
P M Honoré, and A Lozana, and D Defalque, and A Estratiou
January 1981, Acta clinica Belgica,
P M Honoré, and A Lozana, and D Defalque, and A Estratiou
January 1981, Acta clinica Belgica,
P M Honoré, and A Lozana, and D Defalque, and A Estratiou
February 1970, Archives of disease in childhood,
P M Honoré, and A Lozana, and D Defalque, and A Estratiou
February 1982, Journal of medical microbiology,
P M Honoré, and A Lozana, and D Defalque, and A Estratiou
July 1980, Acta paediatrica Scandinavica,
P M Honoré, and A Lozana, and D Defalque, and A Estratiou
March 1979, Obstetrics and gynecology,
Copied contents to your clipboard!